HM15211
A First-in-human Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HM15211(Efocipegtrutide)
Hanmi · Phase 1 · Completed · Enrollment 41
| Arm | Nausea | Vomiting | Diarrhea | Discontinuation | Deaths |
|---|---|---|---|---|---|
| Cohort 1 | n/r | n/r | n/r | n/r | 0 |
| Cohort 2 | n/r | n/r | n/r | n/r | 0 |
| Cohort 3 | n/r | n/r | n/r | n/r | 0 |
| Cohort 4 | n/r | n/r | n/r | n/r | 0 |
| Cohort 5 | n/r | n/r | n/r | n/r | 0 |
A count stays a count. This page does not turn a count into a percent.